The economic value of knowing BRCA status:

BRCA BRCA1 BRCA2 cost-effectiveness olaparib ovarian cancer recurrent epithelial ovarian

Journal

Expert review of pharmacoeconomics & outcomes research
ISSN: 1744-8379
Titre abrégé: Expert Rev Pharmacoecon Outcomes Res
Pays: England
ID NLM: 101132257

Informations de publication

Date de publication:
Mar 2023
Historique:
pubmed: 25 1 2023
medline: 25 2 2023
entrez: 24 1 2023
Statut: ppublish

Résumé

This study aimed to estimate the incremental lifetime effects, costs, and net monetary benefit (NMB) of knowing Incremental NMB (INMB) was calculated as the average net monetized benefit of knowing Knowing BRCA information for ROC patients provided an additional monetized value of $3,528 in (payer) and $3,194 (society). Escalated to all ROC patients in the U.S. and future incidence ROC estimates, knowing The economic value of knowing

Sections du résumé

BACKGROUND UNASSIGNED
This study aimed to estimate the incremental lifetime effects, costs, and net monetary benefit (NMB) of knowing
METHODS UNASSIGNED
Incremental NMB (INMB) was calculated as the average net monetized benefit of knowing
RESULTS UNASSIGNED
Knowing BRCA information for ROC patients provided an additional monetized value of $3,528 in (payer) and $3,194 (society). Escalated to all ROC patients in the U.S. and future incidence ROC estimates, knowing
CONCLUSIONS UNASSIGNED
The economic value of knowing

Identifiants

pubmed: 36691923
doi: 10.1080/14737167.2023.2169136
doi:

Substances chimiques

BRCA1 protein, human 0
BRCA2 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

317-325

Auteurs

Mok Oh (M)

Department of Pharmacy Practice & Science, University of Arizona College of Pharmacy, Tucson, AZ, United States.

Ali McBride (A)

The University of Arizona Cancer Center, North Campus, AZ, USA.

Sandipan Bhattacharjee (S)

Department of Pharmacy Practice & Science, University of Arizona College of Pharmacy, Tucson, AZ, United States.

Marion Slack (M)

Department of Pharmacy Practice & Science, University of Arizona College of Pharmacy, Tucson, AZ, United States.
Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA.

Joanne Jeter (J)

University of Utah Health Huntsman Cancer Institute, Salt Lake City, AZ, USA.

Ivo Abraham (I)

Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH